![Berkshire Hathaway Inc closes position in TEVA / Teva Pharmaceutical Industries Ltd. - 13F, 13D, 13G Filings - Fintel.io Berkshire Hathaway Inc closes position in TEVA / Teva Pharmaceutical Industries Ltd. - 13F, 13D, 13G Filings - Fintel.io](https://images.fintel.io/us-TEVA-berkshire-hathaway.png)
Berkshire Hathaway Inc closes position in TEVA / Teva Pharmaceutical Industries Ltd. - 13F, 13D, 13G Filings - Fintel.io
A190E9 | Teva Pharmaceutical Finance Netherlands II BV-Anleihe: 3,250 % bis 15.04.2022 | finanzen.net
Tear Sheet: Teva Pharmaceuticals Faces Pressure From Competing Generics, Seeks to Delever Quickly After Actavis Acquisition - Reorg
![Teva Announces Early Tender Results of its Debt Tender Offer, Increase of the Maximum Tender Amount and Election of Early Settlement - FactEntry Teva Announces Early Tender Results of its Debt Tender Offer, Increase of the Maximum Tender Amount and Election of Early Settlement - FactEntry](https://www.factentry.com/wp-content/uploads/2021/11/Teva.png)
Teva Announces Early Tender Results of its Debt Tender Offer, Increase of the Maximum Tender Amount and Election of Early Settlement - FactEntry
![Capital Research Global Investors ownership in TEVA / Teva Pharmaceutical Industries Ltd. - 13F, 13D, 13G Filings - Fintel.io Capital Research Global Investors ownership in TEVA / Teva Pharmaceutical Industries Ltd. - 13F, 13D, 13G Filings - Fintel.io](https://images.fintel.io/us-TEVA-capital-research-global-investors.png)
Capital Research Global Investors ownership in TEVA / Teva Pharmaceutical Industries Ltd. - 13F, 13D, 13G Filings - Fintel.io
![Teva Pharmaceutical Industries. Information about the issuer. (LEI 549300BAFGM4RC74ZJ94, SWIFT TEVPILITXXX). News and credit ratings. Tables with accounting and financial reports. Teva Pharmaceutical Industries. Information about the issuer. (LEI 549300BAFGM4RC74ZJ94, SWIFT TEVPILITXXX). News and credit ratings. Tables with accounting and financial reports.](https://data.cbonds.com/organisations_logos/13739/1506089713teva.png)
Teva Pharmaceutical Industries. Information about the issuer. (LEI 549300BAFGM4RC74ZJ94, SWIFT TEVPILITXXX). News and credit ratings. Tables with accounting and financial reports.
A1ZZHS | Teva Pharmaceutical Finance Netherlands II BV-Anleihe: 1,250 % bis 31.03.2023 | finanzen.net
![Positive Risk Environment, With Much Tighter Credit Spreads Across Both DM & EM | ϕpost: News & Analyses of Capital Markets Positive Risk Environment, With Much Tighter Credit Spreads Across Both DM & EM | ϕpost: News & Analyses of Capital Markets](https://images.prismic.io/phipost/b783a218-a5bb-4cf1-a1a4-65a1400f39a3_2021-12-07+Petrobras+%26+Pemex+5Y+USD+CDS+Spreads.png?auto=compress%2Cformat&fit=max&q=60&w=1600&h=777)
Positive Risk Environment, With Much Tighter Credit Spreads Across Both DM & EM | ϕpost: News & Analyses of Capital Markets
![BlackRock Inc. ownership in TEVA / Teva Pharmaceutical Industries Ltd. - 13F, 13D, 13G Filings - Fintel.io BlackRock Inc. ownership in TEVA / Teva Pharmaceutical Industries Ltd. - 13F, 13D, 13G Filings - Fintel.io](https://images.fintel.io/us-TEVA-blackrock.png)
BlackRock Inc. ownership in TEVA / Teva Pharmaceutical Industries Ltd. - 13F, 13D, 13G Filings - Fintel.io
![Most Active Foreign Bonds 29.12.2021 – ADCB Finance, Münchener Hypothekenbank, Athene, Citigroup, New York Life, Transpower New Zealand, Nordea Bank, Teva Pharma, Russian Railways – Financial Markets Blog – by Zuberbühler Associates AG Most Active Foreign Bonds 29.12.2021 – ADCB Finance, Münchener Hypothekenbank, Athene, Citigroup, New York Life, Transpower New Zealand, Nordea Bank, Teva Pharma, Russian Railways – Financial Markets Blog – by Zuberbühler Associates AG](https://zuberbuehlerassociates.files.wordpress.com/2021/12/foreign-bonds-2021-12-30_4.png)